Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay R Lieberman

Showing results (21-30 of 305) with videos related to

Pageof 31
Sort By:
American Journal of Orthopedics (Belle Mead, N.J.)|September 28, 2002
Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplastyPeter G Whang, Jay R Lieberman
Arthroplasty Today|April 26, 2019
Battling the opioid epidemic: lessons learned and management strategiesMohamad J Halawi, Jay R Lieberman
Arthritis Research & Therapy|July 20, 2007
Tumor metastasis to boneMandeep S Virk, Jay R Lieberman
The Journal of Arthroplasty|June 16, 2018
Opioids in Total Joint Arthroplasty: Moving ForwardMohamad J Halawi, Jay R Lieberman
The Journal of the American Academy of Orthopaedic Surgeons|October 11, 2002
Low-molecular-weight herapinPeter G Whang, Jay R Lieberman
Arthritis Research & Therapy|December 4, 2012
Biologic adjuvants for fracture healingMandeep S Virk, Jay R Lieberman
The New England Journal of Medicine|February 18, 2016
A Randomized, Controlled Trial of Total Knee ReplacementDavid D Teuscher, Jay R Lieberman
The Journal of the American Academy of Orthopaedic Surgeons|June 2, 2021
Spinopelvic Biomechanics and Total Hip Arthroplasty: A Primer for Clinical PracticeNathanael D Heckmann, Jay R Lieberman
The Journal of Bone and Joint Surgery. American Volume|March 20, 2008
Gene therapy applications for fracture-healingBradley C Carofino, Jay R Lieberman
Clinical Orthopaedics and Related Research|December 4, 2003
Bone graft for revision hip arthroplasty: biology and future applicationsSeth C Gamradt, Jay R Lieberman
Pageof 31

Showing results (21-30 of 305) with videos related to

Sort By:
Pageof 31
American Journal of Orthopedics (Belle Mead, N.J.)|September 28, 2002
Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplastyPeter G Whang, Jay R Lieberman
Arthroplasty Today|April 26, 2019
Battling the opioid epidemic: lessons learned and management strategiesMohamad J Halawi, Jay R Lieberman
Arthritis Research & Therapy|July 20, 2007
Tumor metastasis to boneMandeep S Virk, Jay R Lieberman
The Journal of Arthroplasty|June 16, 2018
Opioids in Total Joint Arthroplasty: Moving ForwardMohamad J Halawi, Jay R Lieberman
The Journal of the American Academy of Orthopaedic Surgeons|October 11, 2002
Low-molecular-weight herapinPeter G Whang, Jay R Lieberman
Arthritis Research & Therapy|December 4, 2012
Biologic adjuvants for fracture healingMandeep S Virk, Jay R Lieberman
The New England Journal of Medicine|February 18, 2016
A Randomized, Controlled Trial of Total Knee ReplacementDavid D Teuscher, Jay R Lieberman
The Journal of the American Academy of Orthopaedic Surgeons|June 2, 2021
Spinopelvic Biomechanics and Total Hip Arthroplasty: A Primer for Clinical PracticeNathanael D Heckmann, Jay R Lieberman
The Journal of Bone and Joint Surgery. American Volume|March 20, 2008
Gene therapy applications for fracture-healingBradley C Carofino, Jay R Lieberman
Clinical Orthopaedics and Related Research|December 4, 2003
Bone graft for revision hip arthroplasty: biology and future applicationsSeth C Gamradt, Jay R Lieberman
Pageof 31